Your Annual Cholesterol Management Update: Reducing ASCVD Risk

Description

Finally—cardiovascular disease (CV) is becoming more manageable. However, as evidence-based therapies emerge to reduce CV events, including mortality, selecting the appropriate therapy for patients is still a challenge. Health care providers can reference the 2017 American College of Cardiology and National Lipid Association evidence-based, patient-centered recommendations for management of dyslipidemia. Attend this expert-led session to learn how to lower atherosclerotic cardiovascular disease (ASCVD), the role of nonstatin therapies in ASCVD risk reduction, and how to identify patients who may be appropriate for treatment.

Pharmacist Learning Objectives

At the completion of this application-based activity, participants will be able to:

  1. Discuss recent evidence-based updates in atherosclerotic cardiovascular disease risk reduction and cholesterol management.
  2. Recommend treatment strategies for patients with hyperlipidemia who complain of statin-associated muscle symptoms.
  3. Discuss the evidence evaluating the efficacy and safety of nonstatin therapies in patients with dyslipidemia, including the impact on long-term cardiovascular outcomes.
  4. Describe recommendations for appropriate use of nonstatin therapies based on recommendations from authoritative national organizations.
  5. List investigational drug therapies for treatment of dyslipidemia.
  6. Formulate patient-centered treatment plans for patients with hyperlipidemia, beyond statin therapy.
 
 
 
Speakers:
Joseph
Joseph Saseen, PharmD, BCPS, BCACP
Professor and Vice Chair
University of Colorado
 
Janelle
Janelle Ruisinger, PharmD, FAPhA
Clinical Professor and PGY1 Community-Based Residency Director
University of Kansas School of Pharmacy
 
Learning Level: Level 2
Track: Pharmacist Clinical Patient Care Services, Community-Based Pharmacy Practice, Ambulatory Care
Session Time Slot(s): 
Date: 
Monday, March 25
Time: 
7:30 AM - 9:30 AM
Room: 
Washington State Convention Center - Ballroom 6E
ACPE Pharmacist: 0202-0000-19-083-L01-P
CEUs Pharmacist: .2
Activity Type:
Application-based